AstraZeneca Breakfast Symposium - Severe Asthma: Beyond the Biomarkers’
| Monday, March 24, 2025 |
| 7:15 AM - 8:15 AM |
| E1 |
|
Sponsored By:
AstraZeneca
|
Details
We are pleased to invite you to the AstraZeneca Sponsored Breakfast Symposium, “Severe Asthma - Beyond theBiomarkers.” There have been significant advances in the understanding and management of severe asthma in recenttimes with the development of novel biologic therapies. Despite this, optimal selection and use of targeted therapies maybe complicated by disease heterogeneity, as severe asthma patients frequently present with a range of clinical features,phenotypes and comorbidities.This symposium will address a range of topical challenges in severe asthma management, including the role of biomarkersand patient phenotypes in therapy selection, consideration of upstream and downstream molecular targets, assessmentand optimisation of patient response, and considerations for switching biologic agents. Expert speakers will discuss theevidence supporting current severe asthma management strategies, and how these can be practically integrated intoclinical practice.
Speaker
Marco Caminati
Associate Professor
University of Verona, Italy
The evolution of phenotyping and profiling asthma
7:15 AM - 7:45 AMBiography
Associate Professor Marco Caminati has a clinical and scientific interest on asthma, and rare dysimmune conditionswith hyper-eosinophilia including vasculitis, hypereosinophilic syndromes, eosinophilic gastrointestinal disorders,with a special focus on new targeted therapies. He serves as Secretary of the European Academy of Allergy andClinical Immunology Task Forces on ABPA and HES. He is also Member of the World Allergy Organisation AdultAsthma and Biologic Therapies in Allergic Diseases and Member of the International Eosinophil Society Outreachand Diversity Committees. He is part of the Global Initiative for Asthma (GINA) Italian Working Group and of theScientific Committee of SANI - Project for the Severe Asthma Network Italy.
Prof John Blakey
Respiratory and Sleep Medicine Consultant
Sir Charles Gardner Hospital
Defining and managing risk in asthma
7:45 AM - 8:05 AMBiography
John Blakey is Head of Respiratory Medicine at Sir Charles Gairdner Hospital in Perth WA. He has expertise in
asthma, related airways diseases such as chronic cough and ILO, and the environmental impact of inhaled
medicines.
He continues to be research active through an adjunct Clinical Professor position with Curtin University, including
grant funded and commercial studies with particular interest in real world and service delivery research. John
undertakes advisory and committee work for Asthma Australia, and is the immediate past president of the WA
branch of TSANZ for whom he is also contributing to position papers. He is a member of the steering committees
for the ambitious CURE, Future of Asthma, and ANZRAP projects.
All Speakers
Q&A
8:05 AM - 8:15 AMBiography
